|
|
|
51-200 employees
View all
|
|
Pharmaceuticals
|
|
3F, No. 41, Lane 221, Kang Chien Rd., Neihu Dist., Taipei, TW
|
|
focusing on the development and commercialization of "High Barrier to Entry" generic drugs. TWi focuses primarily on the development of Paragraph IV and high technical barrier generic drugs requiring strong science and technical know-how, as well as under-serviced mature molecules to meet market needs. For more information about TWi Corporate and "High Barrier to Entry" generics, please click here to visit www.twipharma.com.
Our goals are to expand our market presence in the United States as a strong industry partner, and to continue to identify, acquire, develop, license and launch technically challenging or mature molecule generic drugs.
|
TWi Pharmaceuticals, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
33.33%
|
The widely used TWi Pharmaceuticals, Inc. email format is {first}.{last} (e.g. [email protected]) with 33.33% adoption across the company.
To contact TWi Pharmaceuticals, Inc. customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.